ABOUT THE SERVICE
Tune Therapeutics’ proprietary TEMPO platform enables precise epigenetic control, allowing for the activation, silencing, and fine-tuning of gene expression without altering the DNA sequence. This technology has the potential to target a wide range of diseases, including cancer, genetic disorders, and age-related conditions.
Information is owner-confirmed
Last updated 1 month ago
Price range